» Articles » PMID: 19340605

A Pilot Study of Gas Chromatograph/mass Spectrometry-based Serum Metabolic Profiling of Colorectal Cancer After Operation

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2009 Apr 3
PMID 19340605
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is mainly depended on the radical operation, the changing energy metabolism after operation reflects the extent, the magnitude, and the degree of surgical trauma. The aim of this study was to analyse the biochemical perturbation in the serum of CRC after operation and to evaluate their involvement in the progression of CRC. Gas chromatograph-mass spectrometry (GC-MS) in combination with pattern recognition techniques (Partial least squares discriminant analysis, supervised clustering analysis) was used to analyze serum metabolome in 30 CRC patients. A 34 endogenous metabolites included amino acid, fatty acid, carbohydrate and other intermediate metabolites were identified. Partial least squares discriminant analysis based on these metabolites discriminated preoperative from postoperative CRC group. Compared with preoperative CRC patients group, decreases in L-valine, 5-oxo-L-proline, 1-Deoxyglucose, D-turanose, D-maltose, arachidonic acid and hexadecanoic acid levels and increases in L-tyrosine levels were observed in postoperative CRC patients group. The result demonstrated the GC-MS technique is an valuable tool for the characterization of the metabolic perturbation, and the metabolomic study will certainly benefit for monitoring the nutrition state of CRC patients, the prognosis and therapy evaluation of CRC patients after operation.

Citing Articles

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia.

van Vorstenbosch R, Cheng H, Jonkers D, Penders J, Schoon E, Masclee A Metabolites. 2023; 13(1).

PMID: 36676980 PMC: 9865897. DOI: 10.3390/metabo13010055.


Integrating Two-Dimensional Gas and Liquid Chromatography-Mass Spectrometry for Untargeted Colorectal Cancer Metabolomics: A Proof-of-Principle Study.

Yuan F, Kim S, Yin X, Zhang X, Kato I Metabolites. 2020; 10(9).

PMID: 32854360 PMC: 7569982. DOI: 10.3390/metabo10090343.


Global serum metabolomics profiling of colorectal cancer.

Amir Hashim N, Ab-Rahim S, Suddin L, Ahmad Saman M, Mazlan M Mol Clin Oncol. 2019; 11(1):3-14.

PMID: 31289671 PMC: 6535638. DOI: 10.3892/mco.2019.1853.


Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).

Liesenfeld D, Habermann N, Toth R, Owen R, Frei E, Staffa J Metabolomics. 2017; 11(4):998-1012.

PMID: 29250455 PMC: 5730072. DOI: 10.1007/s11306-014-0758-3.


Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.

Manne U, Jadhav T, Putcha B, Samuel T, Soni S, Shanmugam C Curr Colorectal Cancer Rep. 2017; 12(6):332-344.

PMID: 28626361 PMC: 5469416. DOI: 10.1007/s11888-016-0338-1.


References
1.
Nobeli I, Thornton J . A bioinformatician's view of the metabolome. Bioessays. 2006; 28(5):534-45. DOI: 10.1002/bies.20414. View

2.
Hung K, Chung D . Colorectal cancer screening: today and tomorrow. South Med J. 2006; 99(3):240-6. DOI: 10.1097/01.smj.0000203817.89741.29. View

3.
Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T . Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover. Mol Cancer. 2008; 7:72. PMC: 2569965. DOI: 10.1186/1476-4598-7-72. View

4.
Pasikanti K, Ho P, Chan E . Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 871(2):202-11. DOI: 10.1016/j.jchromb.2008.04.033. View

5.
Hansell D, Davies J, Burns H . Effects of hepatic metastases on resting energy expenditure in patients with colorectal cancer. Br J Surg. 1986; 73(8):659-62. DOI: 10.1002/bjs.1800730828. View